These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 80152)

  • 1. [Search for new antitumor antibiotics in the bleomycin group].
    Gauze GF; Maksimova TS; Ol'khovatova OL
    Antibiotiki; 1978 Aug; 23(8):675-6. PubMed ID: 80152
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Screening for new antitumor antibiotics of the bleomycin group.
    Gause GF; Maximova TS; Olchovatova OL
    Cancer Treat Rep; 1978 Aug; 62(8):1227-8. PubMed ID: 80273
    [No Abstract]   [Full Text] [Related]  

  • 3. In vitro evaluation of the new anticancer agents KT6149, MX-2, SM5887, menogaril, and liblomycin using cisplatin- or adriamycin-resistant human cancer cell lines.
    Ohe Y; Nakagawa K; Fujiwara Y; Sasaki Y; Minato K; Bungo M; Niimi S; Horichi N; Fukuda M; Saijo N
    Cancer Res; 1989 Aug; 49(15):4098-102. PubMed ID: 2472873
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the sequences at specific sites on DNA cleaved by the antitumor antibiotics talisomycin and bleomycin.
    Mirabelli CK; Beattie WG; Huang CH; Prestayko AW; Crooke ST
    Cancer Res; 1982 Apr; 42(4):1399-404. PubMed ID: 6174223
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of microbial and tumor cell adaptation to rubomycin on their uptake of rubomycin and carminomycin].
    Ostanina LN; Averbukh LA; Karpov VL; Dudnik IuV; Liashenko VA
    Antibiotiki; 1978 Sep; 23(9):837-40. PubMed ID: 697342
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Studies on the mechanism of drug resistance in tumor cells and a new antitumor antibiotic].
    Tanaka N
    Gan To Kagaku Ryoho; 1984 Dec; 11(12 Pt 2):2666-73. PubMed ID: 6210060
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The ShBle resistance determinant from Streptoalloteichus hindustanus is expressed in Haloferax volcanii and confers resistance to bleomycin.
    Nuttall SD; Deutschel SE; Irving RA; Serrano-Gomicia JA; Dyall-Smith ML
    Biochem J; 2000 Mar; 346 Pt 2(Pt 2):251-4. PubMed ID: 10677341
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Mutagenesis in Streptomycete cultures exposed to bleomycin].
    Lapchinskaia OA; Siniagina OP; Filicheva VA; L'vova NA
    Antibiotiki; 1982 Feb; 27(2):147-50. PubMed ID: 6175272
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Role of antibiotics in the ecology of actinomycetes].
    Gauze GF; Maksimova TS; Ol'khovatova OL
    Antibiotiki; 1979 Feb; 24(2):83-6. PubMed ID: 434803
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel transformation system using a bleomycin resistance marker with chemosensitizers for Aspergillus oryzae.
    Suzuki S; Tada S; Fukuoka M; Taketani H; Tsukakoshi Y; Matsushita M; Oda K; Kusumoto K; Kashiwagi Y; Sugiyama M
    Biochem Biophys Res Commun; 2009 May; 383(1):42-7. PubMed ID: 19324021
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of DNA superhelical changes induced by ethidium bromide on the DNA-degrading activity of two antitumor antibiotics, bleomycin and phleomycin.
    Huang CH; Mirabelli CK; Mong S; Crooke ST
    Cancer Res; 1983 Jun; 43(6):2849-56. PubMed ID: 6189587
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Secondary microbial metabolites with potentials for antineoplastic actions: antineoplastic antibiotics and immunopotentiators].
    Umezawa H
    Gan To Kagaku Ryoho; 1983 Apr; 10(4 Pt 2):1071-86. PubMed ID: 6191672
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Validity of chromosome analysis and bleomycin sensitivity assay in the prevention of head and neck cancer in Hungary].
    Székely G; Remenár E; Kásler M; Bodrog A; Gundy S
    Orv Hetil; 2001 Mar; 142(12):611-6. PubMed ID: 11324219
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Systematic position and variability of the producent of antitumor antibiotic bruneomycin].
    Kudrina ES; Ol'khovatova OL; Murav'eva LI; Gauze GF
    Antibiotiki; 1966 May; 11(5):400-5. PubMed ID: 4967040
    [No Abstract]   [Full Text] [Related]  

  • 15. Structure and function of "metalloantibiotics".
    Ming LJ
    Med Res Rev; 2003 Nov; 23(6):697-762. PubMed ID: 12939790
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent studies on antibiotics and small molecular immunomodulators with potential usefulness in treating lung cancer: Part I - Antitumor antibiotics and their derivatives.
    Umezawa H
    Int J Clin Pharmacol Ther Toxicol; 1982 Jan; 20(1):12-8. PubMed ID: 6173340
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of structural modifications of anthracyclines on the ability to overcome drug resistance of cancer cells.
    Wasowska M; Wietrzyk J; Opolski A; Oszczapowicz J; Oszczapowicz I
    Anticancer Res; 2006; 26(3A):2009-12. PubMed ID: 16827137
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Optimal administration schedules of antineoplastic antibiotics based on their pharmacokinetics, with special reference to bleomycins and anthracyclines].
    Ota K; Goto T; Fukushima M; Ariyoshi Y
    Gan To Kagaku Ryoho; 1982 Aug; 9(8):1352-61. PubMed ID: 6191712
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bleomycin.
    Lazo JS; Sebti SM
    Cancer Chemother Biol Response Modif; 1997; 17():40-5. PubMed ID: 9551207
    [No Abstract]   [Full Text] [Related]  

  • 20. Additive effects of bleomycin and neocarzinostatin on degradation of DNA, inhibition of DNA polymerase beta, and cell growth.
    Müller WE; Maidhof A; Arendes J; Geurtsen W; Zahn RK; Schmidseder R
    Cancer Res; 1979 Sep; 39(9):3768-73. PubMed ID: 89904
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.